GALT compared with ECOR: revenue, margins and what each company keeps, and the suppliers and customers both name

GALTGalectin Therapeutics Inc

Mkt capRevenueRevenue

ECORelectroCore, Inc.

Mkt capRevenueRevenue

Compare

GALTGalectin Therapeutics Inc

ECORelectroCore, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only GALT 6

—Perspectum Diagnosticsunlistedsupplier

—Covance (now known as Fortrea)unlistedsupplier

—Dr. Ari Rosenbergunlistedsupplier

—Dr. Chetan Bettegowdaunlistedsupplier

2 more · GALT chain ›

Shared 0

No shared counterparties.

Only ECOR 1

—Joerns Healthcareunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

GALTGalectin Therapeutics Inc

3.31▼−5.93%

Mkt cap$334.8MRevenue—Revenue—

ECORelectroCore, Inc.

7.50▼−7.52%

Regular sessionOct 30 '26

Mkt cap$67.8MRevenue$9MQ2 FY26Revenue$32MFY25

Compare

Regular sessionOct 30 '26

GALTGalectin Therapeutics Inc

ECORelectroCore, Inc.

3.31▼−5.93%

Price

7.50▼−7.52%

$334.8M

Mkt cap

$67.8M

—

Revenue

$9MQ2 FY26

—

Revenue

$32MFY25

GALT3.31▼−5.93%vsECOR7.50▼−7.52%Regular sessionOct 30 '26